ADL
EXAS

Asset Dedication LLC’s Exact Sciences EXAS Stock Holding History

Asset Dedication LLC’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-255
Closed -$25.9K – 1140
2025
Q4 		$25.9K Hold
255
– – ﹤0.01% 615
2025
Q3 		$14K Hold
255
– – ﹤0.01% 742
2025
Q2 		$13.6K Hold
255
– – ﹤0.01% 770
2025
Q1 		$11K Hold
255
– – ﹤0.01% 749
2024
Q4 		$14.3K Buy
+255
New +$15.9K ﹤0.01% 710

Other funds holding EXAS

VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
PRS
Pinkerton Retirement Specialists Coeur D Alene, Idaho $1.1B AUM 30.57% 1-Year Est. Return
PWMAG
Pinnacle Wealth Management Advisory Group Red Bank, New Jersey $1.46B AUM 22.77% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Asset Dedication LLC's EXAS Position: Q1 2026 in Review

Asset Dedication LLC sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 255 shares — an estimated $25.9K sold.

Asset Dedication LLC first reported a position in EXAS in Q4 2024 and held it in 5 quarters. The position peaked at $25.9K in Q4 2025. 6 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • Asset Dedication LLC reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • Asset Dedication LLC sold 255 Exact Sciences shares in Q1 2026, an estimated $25.9K.
  • Asset Dedication LLC first reported a position in Exact Sciences in Q4 2024 and held it in 5 quarters.
  • Asset Dedication LLC's Exact Sciences position peaked at $25.9K in Q4 2025.
  • 6 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Asset Dedication LLC's 13F filing for Q1 2026, filed 29 May 2026.